Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Winner

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Headache|April 28, 2011
Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (C-dAS)Richard B Lipton, Aubrey Manack, Judith A Ricci, et al.
Headache|December 6, 2005
Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trialPaul Winner, Eric M Pearlman, Stephen L Linder, et al.
Headache|August 7, 2021
STOP 301: A Phase 3, open-label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD<sup>®</sup> ) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patientsTimothy R Smith, Paul Winner, Sheena K Aurora, et al.
Headache|November 23, 2006
Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safetyPaul Winner, Astrid Gendolla, Catherine Stayer, et al.
Mayo Clinic Proceedings|October 9, 2003
Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studiesPaul Winner, Lisa K Mannix, D Gayla Putnam, et al.
Headache|May 9, 2012
In memoriam: Donald W. Lewis, MD (1951-2012)Andrew D Hershey, Paul Winner, Steve Linder, et al.
Clinical Pharmacokinetics|February 10, 2021
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with MigraineMax Tsai, Emel Serap Monkul Nery, Lisa Kerr, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 10, 2010
Chronic daily headache in children and adolescents: a multi-faceted syndromeShashi S Seshia, Shuu-Jiun Wang, Ishaq Abu-Arafeh, et al.
Journal of Managed Care & Specialty Pharmacy|October 31, 2017
Factors Associated with Direct Health Care Costs Among Patients with MigraineMachaon Bonafede, Qian Cai, Katherine Cappell, et al.
Headache|September 28, 2004
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studiesW Hester Visser, Paul Winner, Kim Strohmaier, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Headache|April 28, 2011
Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (C-dAS)Richard B Lipton, Aubrey Manack, Judith A Ricci, et al.
Headache|December 6, 2005
Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trialPaul Winner, Eric M Pearlman, Stephen L Linder, et al.
Headache|August 7, 2021
STOP 301: A Phase 3, open-label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD<sup>®</sup> ) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patientsTimothy R Smith, Paul Winner, Sheena K Aurora, et al.
Headache|November 23, 2006
Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safetyPaul Winner, Astrid Gendolla, Catherine Stayer, et al.
Mayo Clinic Proceedings|October 9, 2003
Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studiesPaul Winner, Lisa K Mannix, D Gayla Putnam, et al.
Headache|May 9, 2012
In memoriam: Donald W. Lewis, MD (1951-2012)Andrew D Hershey, Paul Winner, Steve Linder, et al.
Clinical Pharmacokinetics|February 10, 2021
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with MigraineMax Tsai, Emel Serap Monkul Nery, Lisa Kerr, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 10, 2010
Chronic daily headache in children and adolescents: a multi-faceted syndromeShashi S Seshia, Shuu-Jiun Wang, Ishaq Abu-Arafeh, et al.
Journal of Managed Care & Specialty Pharmacy|October 31, 2017
Factors Associated with Direct Health Care Costs Among Patients with MigraineMachaon Bonafede, Qian Cai, Katherine Cappell, et al.
Headache|September 28, 2004
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studiesW Hester Visser, Paul Winner, Kim Strohmaier, et al.
Pageof 6